Clinical Trials Directory

Trials / Completed

CompletedNCT01692340

Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans

Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

Tomatoes contain several compounds which may be beneficial for human health and prevention of disease, although this relationship is poorly understood and very controversial. This study uses a new technology to study the absorption and metabolism of three different compounds found in tomatoes. These compounds are called: phytoene, phytofluene, and lycopene. We hypothesize that by studying the absorption and metabolism of these compounds, we may be able to understand how the compounds may influence health and disease processes.

Conditions

Interventions

TypeNameDescription
OTHERIsotopically labeled lycopene, phytoene or phytoflueneWe will administer 10 mg of labeled carotenoid mixed with olive oil and spread on an English muffin for consumption by participants.

Timeline

Start date
2012-02-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2012-09-25
Last updated
2019-03-26
Results posted
2015-10-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01692340. Inclusion in this directory is not an endorsement.

Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans (NCT01692340) · Clinical Trials Directory